ANDA 83242, held by Amarin Pharms. Medroxyprogesterone Acetate.
As of Nov 16, 2026, ANDA 83242 (Amen), held by Amarin Pharms, was first approved by FDA on May 15, 1974, with 21 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 15, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amen10MG ยท tablet;oral | Medroxyprogesterone Acetate | Discontinued |
| Jul 8, 1997 | Supplement 41Manufacturing | Approved | None posted |
| May 5, 1997 | Supplement 40Manufacturing | Approved | None posted |
| Sep 29, 1994 | Supplement 39Manufacturing | Approved | None posted |
| Sep 28, 1994 | Supplement 38Labeling | Approved | None posted |
| Feb 3, 1994 | Supplement 37Labeling | Approved | None posted |
| Jan 29, 1993 | Supplement 36Manufacturing | Approved | None posted |
| Jan 27, 1992 | Supplement 33Manufacturing | Approved | None posted |
| Jun 25, 1991 | Supplement 35Labeling | Approved | None posted |
| Mar 28, 1991 | Supplement 34Manufacturing | Approved | None posted |
| Apr 19, 1990 | Supplement 32Labeling | Approved | None posted |
| May 10, 1989 | Supplement 29Manufacturing | Approved | None posted |
| Feb 10, 1989 | Supplement 31Manufacturing | Approved | None posted |
| Nov 23, 1987 | Supplement 27Manufacturing | Approved | None posted |
| Aug 8, 1986 | Supplement 20Manufacturing | Approved | None posted |
| Mar 25, 1986 | Supplement 23Manufacturing | Approved | None posted |
| Mar 25, 1986 | Supplement 22Manufacturing | Approved | None posted |
| Dec 16, 1985 | Supplement 18Manufacturing | Approved | None posted |
| Dec 16, 1985 | Supplement 17Manufacturing | Approved | None posted |
| Dec 16, 1985 | Supplement 16Manufacturing | Approved | None posted |
| Jun 22, 1984 | Supplement 14Manufacturing | Approved | None posted |
| Jun 22, 1984 | Supplement 13Manufacturing | Approved | None posted |
| May 15, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters